The Pharma Legal Handbook: Egypt

Egypt is the largest pharmaceutical market in North Africa and one of the most significant in the Middle East, with a large domestic manufacturing sector and a well-established regulatory framework. The Central Administration of Pharmaceutical Affairs (CAPA) manages product registration and post-market surveillance, while the Ministry of Health oversees pricing through a system of price controls.

Egypt's Vision 2030 and health sector reform programmes have brought changes to the pharmaceutical regulatory environment, including moves to accelerate registration for innovative medicines and strengthen the framework for clinical trials. The country's large population and growing access to healthcare make it an increasingly important market for international companies.

The Pharma Legal Handbook: Egypt provides comprehensive guidance on pharmaceutical regulation in Egypt, covering CAPA product registration, pricing frameworks, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing rules, and intellectual property protection.